Development of an oral formulation of a metabolite of ketamine, 2R,6R-HNK, as a next-generation antidepressant.

  • Gurvich, Vadim J (PI)

Project: Research project

Project Details

Description

Development of an oral formulation of a metabolite of ketamine, 2R,6R-HNK, as a next-generation antidepressant.
StatusActive
Effective start/end date9/24/1810/31/20

Funding

  • National Institutes of Health

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.